Bacterial Vaginosis: Diagnosis and Treatment
Diagnosis
Clue cells on wet prep indicate bacterial vaginosis (BV), but you must confirm at least two additional Amsel criteria before treating—specifically, vaginal pH >4.5, homogeneous white discharge coating vaginal walls, and/or a positive whiff test (fishy odor with 10% KOH). 1, 2
Diagnostic Criteria (Amsel Criteria)
BV requires three of four findings: 3, 1, 2
- Clue cells on saline wet mount (vaginal epithelial cells densely coated with bacteria, creating stippled appearance with obscured borders) 1, 4
- Vaginal pH >4.5 3, 1, 2
- Homogeneous, thin, white-gray discharge that smoothly coats vaginal walls 3, 1, 2
- Positive whiff test (fishy amine odor before or after adding 10% KOH) 3, 1, 2
Key Diagnostic Pearls
- Clue cells alone are the single most reliable indicator (sensitivity 98.2%, specificity 94.3%), but you still need additional criteria to avoid misdiagnosis and inappropriate treatment. 4, 1
- The combination of clue cells plus positive whiff test achieves 99.5% sensitivity and 98.8% positive predictive value. 4
- When wet mount is equivocal, obtain quantitative Gram stain (Nugent criteria) for definitive confirmation. 1, 5
- Do not culture Gardnerella vaginalis for diagnosis—it lacks specificity because it's isolated in ~50% of asymptomatic women. 3, 1, 5
Critical Pitfall to Avoid
If you see green or frothy discharge despite meeting BV criteria, order NAAT for Trichomonas vaginalis immediately—wet mount detects only 40-80% of trichomoniasis cases, and co-infection is common. 1, 6, 5 Green discharge is pathognomonic for trichomoniasis, not BV. 1
First-Line Treatment
Treat all symptomatic women with metronidazole 500 mg orally twice daily for 7 days—this achieves ~95% cure rate for BV and simultaneously treats trichomoniasis if co-infection exists. 3, 1, 2
Treatment Regimen Details
- Preferred regimen: Metronidazole 500 mg PO BID × 7 days 3, 1, 2
- Alternative regimen: Metronidazole 2 g PO single dose (lower cure rate of 84% vs. 95%, not recommended as first-line) 1
- Advise patients to avoid alcohol during therapy and for ≥24 hours after the last dose to prevent disulfiram-like reaction. 1
Partner Management
Do not treat male sexual partners for BV—partner therapy does not prevent recurrence or alter clinical course. 3, 1 However, if trichomoniasis is confirmed, treat the partner with metronidazole 2 g single dose to prevent reinfection. 1, 6
Special Clinical Scenarios
Pregnant Women
- All symptomatic pregnant women require treatment at any gestational age to relieve symptoms and potentially reduce preterm birth risk. 3, 1
- High-risk asymptomatic pregnant women (prior preterm delivery) may benefit from screening and treatment, though evidence remains uncertain. 3, 1
- Average-risk asymptomatic pregnant women: Do not screen or treat routinely (Grade D recommendation). 1
Before Invasive Gynecologic Procedures
Treat BV even if asymptomatic before surgical abortion, hysterectomy, IUD placement, or endometrial biopsy—this substantially reduces post-procedure pelvic inflammatory disease and endometritis. 3, 1
When Initial Testing Is Negative or Equivocal
If symptoms persist despite negative wet prep: 1, 5
- Order NAAT for T. vaginalis, N. gonorrhoeae, and C. trachomatis (wet mount misses >50% of trichomoniasis) 1, 5
- Consider multiplex NAAT panels (e.g., BD Max Vaginal Panel) for comprehensive detection of BV-associated bacteria, Candida species, and Trichomonas 1, 5
- Obtain vaginal yeast culture if candidiasis suspected but wet mount negative 1, 5
- Consider non-infectious causes (mechanical, chemical, allergic irritation from soaps, douches, lubricants) if no pathogens identified and minimal discharge with vulvar inflammation 3, 1
Recurrence Management
BV recurs in 50-80% of women within one year, necessitating repeated evaluation using the same diagnostic criteria. 1 Consider longer suppressive therapy regimens for recurrent cases, though specific protocols are beyond the scope of initial diagnosis and treatment.